Zeria Pharmaceutical Forecast, price target & analysts
Zeria Pharmaceutical Target price 2025 - Analyst rating & recommendation
Zeria Pharmaceutical Classifications & Recommendation:
Zeria Pharmaceutical Price Target
| Target Price | ¥2,448.00 |
| Price | ¥2,099.00 |
| Potential |
16.63%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Zeria Pharmaceutical 2026 .
The average Zeria Pharmaceutical target price is ¥2,448.00.
This is
16.63%
register free of charge
¥2,520.00
20.06%
register free of charge
¥2,424.00
15.48%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Zeria Pharmaceutical to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zeria Pharmaceutical stock has an average upside potential 2026 of
16.63%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 87.31 | 90.90 |
| 15.30% | 4.11% | |
| EBITDA Margin | 20.67% | 19.11% |
| 4.76% | 7.55% | |
| Net Margin | 11.38% | 7.67% |
| 11.47% | 32.60% |
2 Analysts have issued a sales forecast Zeria Pharmaceutical 2026 . The average Zeria Pharmaceutical sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Zeria Pharmaceutical EBITDA forecast 2026. The average Zeria Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Zeria Pharmaceutical Analysts have issued a net profit forecast 2026. The average Zeria Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 225.42 | 158.07 |
| 28.53% | 29.88% | |
| P/E | 13.20 | |
| EV/Sales | 1.19 |
2 Analysts have issued a Zeria Pharmaceutical forecast for earnings per share. The average Zeria Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Zeria Pharmaceutical...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
